Delhi Eyezone Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.14 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.60 Cr
as on 16-11-2024
- Revenue 50.83%
(FY 2023)
- Profit 57.95%
(FY 2023)
- Ebitda -319.63%
(FY 2023)
- Net Worth 20.53%
(FY 2023)
- Total Assets 29.57%
(FY 2023)
About Delhi Eyezone
The Corporate was formerly known as Narang Healthcare Private Limited. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.14 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mona Narang, Narinder Narang, and Manu Narang serve as directors at the Company.
- CIN/LLPIN
U51397DL2003PTC119306
- Company No.
119306
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Delhi Eyezone?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mona Narang  | Director | 02-Jan-2006 | Current |
| Narinder Narang | Director | 02-Jan-2006 | Current |
| Manu Narang | Director | 07-Mar-2003 | Current |
Financial Performance of Delhi Eyezone.
Delhi Eyezone Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.83% increase. The company also saw a substantial improvement in profitability, with a 57.95% increase in profit. The company's net worth Soared by an impressive increase of 20.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delhi Eyezone?
In 2023, Delhi Eyezone had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 19 Mar 2015 | ₹2.15 M | Open |
Indian Overseas Bank Creation Date: 12 Mar 2015 | ₹1.92 Cr | Open |
Icici Bank Limited Creation Date: 16 Nov 2012 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Delhi Eyezone?
Delhi Eyezone has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delhi Eyezone, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delhi Eyezone's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
